The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Device: Observational Study - no intervention
Observational Study - no intervention
Inclusion Criteria:
- Subject has provided informed consent
- Male or female over the age of 18 years
- The patient is currently hospitalized with a primary diagnosis of Covid-19
Exclusion Criteria:
- Subject is unwilling or unable to wear the vest during hospitalization.
- Subjects who are pregnant.
- Subject is intubated or admitted to ICU
- Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter
defibrillator)
Hackensack University Medical Center
Hackensack, New Jersey, United States
Maimonides Medical Center
Brooklyn, New York, United States